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Abstract  21 
Spent coffee grounds are a potential commercial source of substantial amounts of chlorogenic 22 
acids (CGAs). The aim of this study was to evaluate the stability of spent coffee CGAs using in 23 
vitro simulated gastroduodenal digestion and to investigate their potential absorption using an in 24 
vitro Caco-2 model of human small intestinal epithelium. During in vitro digestion, lactones 25 
were partially degraded while caffeoylquinic and feruloylquinic acids were much more stable. 26 
Transport and metabolism studies showed that 1% of the total CGAs were absorbed and 27 
transported from the apical to the basolateral side of a Caco-2 cell monolayer after 1 h. Lactones 28 
and coumaroylquinic acids showed the rate of highest absorption. Caco-2 cells possessed low 29 
metabolic activity. In conclusion, spent coffee extracts contain large amounts of CGAs, which 30 
remained bioaccessible across the intestinal barrier, albeit to a relatively low degree. 31 
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Introduction 37 
The consumption and development of functional foods have been growing rapidly in recent 38 
years, driven by the increased interest in food that can improve human health. This has resulted 39 
in searches for new bioactive ingredients for products with a potential to contribute to the 40 
prevention and reduction of the risk factor for chronic diseases, or which have the capacity to 41 
enhance key physiological functions. Flavonoids and related phenolic compounds have proven to 42 
be bioactive with a number of beneficial effects on health (Yao et al., 2004; Crozier et al., 2009; 43 
Del Rio et al. 2013; Rodrigues-Mateos et al. 2014). One of the main dietary sources of phenolic 44 
compounds are the millions cup of coffee consumed every day, due to the presence of substantial 45 
amounts of chlorogenic acids (CGAs). However, the levels vary principally as a consequence of 46 
roasting (Moon et al., 2009) and one study found the CQAs per serving in espresso coffees 47 
ranging from 24-422 mg (Crozier et al., 2012). As reviewed by Ludwig et al. (2014a), 48 
epidemiological studies have linked coffee consumption with a reduced risk of type 2 diabetes 49 
(Salazar-Martinez et al., 2004), cardiovascular diseases (Andersen et al., 2006) and some types 50 
of cancer, most notably of the prostate (Li et al., 2013) and skin (cutaneous melanoma) (Loftfield 51 
et al., 2015).  52 
In excess of a million tons of spent coffee grounds, remaining after the commercial 53 
production of coffee beverage, are produced each year and at one time they were used to feed 54 
racehorses until the authorities realised that the grounds contained caffeine, a well-known 55 
stimulant.  Starbucks are reported to be working to convert coffee grounds into laundry 56 
detergents and bioplastics, while Nestlé incinerate the grounds and use it as a heat source to cook 57 
their food products (Kennedy, 2013).  On a smaller scale, coffee grounds are used for compost 58 
and seemingly are much appreciated by earthworms and acid-loving plants such as blueberries 59 
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(Martin & Gershuny, 1992). There are also anecdotal reports of the use of grounds as a slug and 60 
snail repellent, probably at least partially because of the presence of caffeine which acts as a 61 
neurotoxin (Hollingsworth et al., 2002).   62 
The data of Ludwig et al. (2014b) suggests that spend coffee grounds may contain sizable 63 
amounts of residual CGAs which when isolated could offer potential beneficial effects on health. 64 
However, limited data are currently available on the CGA profile of spent coffee grounds and 65 
earlier studies on the absorption and metabolic fate of CGAs have followed the ingestion of 66 
coffee beverage rather than isolated CGAs (Monteiro et al., 2007; Stalmach et al., 2009, 2010, 67 
2014; Renouf et al., 2014).  The aim of the current study was therefore i) to assess the CGA 68 
profile of the spent coffee grounds remaining after the production of filter and espresso coffees, 69 
ii) to investigate the upper gastrointestinal stability of these compounds using an in vitro model 70 
of digestion, and iii) to determine the transport of spent coffee CGAs using Caco-2 cell, an in 71 
vitro model of intestinal absorption. 72 
 73 
Materials and methods 74 
Chemicals 75 
Caffeic acid, ferulic acid, sinapic acid, 5-O-caffeoylquinic acid (5-CQA), caffeine, human saliva 76 
α-amylase (300-1500 U/mg protein), pepsin (674 U/mg), pancreatin (4 x UPS) and bile salts 77 
were purchased from Sigma-Aldrich (Steinheim, Germany). 4,5-Dicaffeoylquinic acid (4,5-78 
DiCQA) was obtained from Phytolab (Vestenbergsgreuth, Germany) and dihydrocaffeic acid and 79 
dihydroferulic acid from Alfa Aeser (Heysham, UK). Culture flasks, Transwell fitted with 80 
polycarbonate membranes were acquired from Corning® Costar® Transwell (Sigma Aldrich, St. 81 
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Louis, US). Dulbecco’s modified Eagle’s medium (DMEM) was purchased from Gibco 82 
Invitrogen (Paisley, UK). The Caco-2 cell line PD7 clone was kindly provided by Dr. Edith Brot-83 
Laroche (Paris, France). All chemicals and reagents used were of analytical grade from Panreac 84 
(Barcelona, Spain), Fisher Scientific (Loughborough, UK), and Sigma Aldrich (Steinheim, 85 
Germany).  86 
 87 
Coffee samples 88 
Medium roasted coffee beans from Guatemala (Arabica) and Vietnam (Robusta) were provided 89 
by Unión Tostadora S.A (Logroño, Spain). The beans were ground to a powder in a Moulinex 90 
coffee grinder for 20 seconds immediately before sample preparation. 91 
 92 
Spent coffee extract preparation  93 
Arabica filter (24 g coffee/ 400 ml) and Robusta espresso (7g coffee/ 45 ml) coffee brews were 94 
prepared to obtain spent coffee. Spent coffee extracts were prepared according to the method 95 
described by Bravo et al. (2012). First, dried spent coffee was defatted with petroleum ether 96 
(1:11, w/v) for 3 h at 60 °C in a Soxhlet extraction system (Extraction Unit B-811 Standard 97 
Büchi, Flawil, Switzerland). Then, spent Arabica coffee was extracted with 400 ml of water 98 
using a filter coffeemaker (model Avantis 70 Inox). Extraction took approximately 6 min at 90 99 
°C.  Aqueous spent coffee extracts and coffee brews were freeze-dried and stored at–18 ºC. Both 100 
spent coffee extracts yielded a recovery of 8 mg lyophilized per ml of extract. Coffee brews 101 
recovery were for Arabica filter 11 mg lyophilized/ ml and for Robusta expresso 25 mg 102 
lyophilized /ml. 103 
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 104 
In vitro digestion 105 
A three step in vitro digestion was carried out in a bioreactor according to Pastoriza et al. (2011). 106 
Briefly, 2 g of each spent extract was dissolved in 200 ml of water and transferred into a vessel 107 
placed in a water bath at 37°C. The vessel was magnetically stirred and connected to a pH 108 
sensor. Before each step the sample was sparged with N2 to maintain a reduced O2 atmosphere. 109 
The three steps were carried out in absence of light. First, oral digestion was performed by 110 
adding 500 μl of an α-amylase solution (32.5 mg of α-amylase dissolved in 25 ml 1 mM CaCl2, 111 
pH 7.0) and incubating for 15 min. The second gastric digestion step was carried out at pH 2.5 112 
with HCl 6N and it was initiated by adding 547 μl of a pepsin solution containing 0.05 g of 113 
pepsin/g of lyophilized spent coffee. After a 2 h incubation the gastric digestion was stopped by 114 
raising the pH to 6.5 with 0.1 M NaHCO3. Finally for intestinal digestion, 5 ml of a mixture of 115 
pancreatin and bile salts (0.1 g of pancreatin and 0.625 g of bile salts in 25 ml of 1 M NaHCO3) 116 
was added to the vessel. The pH was adjusted to pH 7.5 with 0.1 M NaHCO3, and samples 117 
incubated for 2 h. After each step an aliquot was collected, and the enzymes were inactivated 118 
with heat treatment (4 min at 100 ºC), after which the samples were immediately cooled, freeze-119 
dried and stored at –18 ºC prior to analysis. Each experimental condition was tested in triplicate.  120 
For CGA analysis, the freeze dried spent coffee extracts and the digested samples were 121 
reconstituted with distilled water, centrifuged at 16.2 g for 5 min and filtered with 0.45 µm pore 122 
size, 13 mm, Milex-HV filters (Millipore, Bedford, MA, USA), and diluted 20-fold with distilled 123 
water. 124 
 125 
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Transport and metabolism experiments using Caco-2 cells 126 
Caco-2 cells were cultured in DMEM supplemented as previously describe Fanjul et al. (2012). 127 
Once the cells reached 80% confluence, they were dissociated with 0.05% trypsin-EDTA and 128 
sub-cultured on 25 or 75 cm2 plastic flasks at a 25 × 104 cells/cm2 density. Caco-2 cells were 129 
seeded on Transwell inserts (12 mm diameter, 1.12 cm2 growth area) at a density of 130 
6 × 104 cells/cm2. Culture medium was replaced every 2 days. Cell confluence was confirmed by 131 
transepithelial electrical resistance (TEERS) measurements. Transport experiments were 132 
performed at 17–21 days post-seeding according to Farrell et al. (2012). Lyophilised, digested 133 
Arabica spent coffee was redissolved in DMEM (15 mg/ml, pH 7.4). The culture medium was 134 
aspirated and 1 ml test solution was added in the apical side and 2 ml of DMEM pH 7.4 in the 135 
basal side. The incubation period was 0.5 and 1 hour at 37ºC. At the end of the incubation period 136 
media from the apical and basal sides were collected, the monolayer was washed with DMEM, 137 
and cells were scraped into sterile water and sonicated for 30 s. Samples were cooled 138 
immediately, freeze-dried and stored at –18 ºC. Each experimental condition was tested in 139 
triplicate. 140 
For the metabolism experiment, Caco-2 cells were incubated with 1 ml of standard 141 
solutions of either 5-CQA (0.9 µM), 4,5-DiCQA (0.2 µM), caffeic acid (2.5 µM), ferulic acid 142 
(0.7 μM), dihydrocaffeic acid (2.5 μM) or dihydroferulic acid (0.7 μM) in DMSO (0.1%). The 143 
incubation period was 0.5 and 1 h at 37ºC, then samples were removed and stored as described 144 
above. Each experimental condition was tested in triplicate. For CGA analysis culture solution 145 
and cells were extracted and deproteinated according Stalmach et al. (2009) with some 146 
modifications. Each sample was resuspended in 500 µl of methanol containing 1% formic acid 147 
and 20 mmol/l of sodium diethydithiocarbamate and spiked with sinapic acid (20 µl) as an 148 
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internal standard. The samples in Eppendorf tubes were mixed using a flat shaker at a speed of 149 
400 rpm for 5 min at room temperature, before being centrifuged for 10 min at 4ºC. The 150 
supernatant was collected and the pellet was re-extracted as describe above. The two 151 
supernatants were combined and reduced to dryness in vacuo and resuspended in HPLC mobile 152 
phase. Each experimental condition was tested in triplicate. 153 
 154 
Qualitative and quantitative analysis of CGAs and hydroxycinnamates by HPLC-PDA-155 
MSn 156 
CGAs were analyzed using a Surveyor HPLC with a photodiode array (PDA) detector scanning 157 
from 200 to 600 nm, an autosampler cooled at 6 ºC, and a LCQ Duo ion trap mass spectrometer 158 
fitted with an electrospray interface (ESI) (Thermo Fisher Scientific, San Jose, CA). The 159 
injection volume was 100 µl of sample. HPLC was performed at 40 ºC with a Synergi 4-mm 160 
Polar-RP 250 x 4.6 mm reversed-phase column (Phenomenex, Macclesfield, UK). The mobile 161 
phase consisted of 0.1 % aqueous formic acid (solvent A) and 100% methanol (solvent B). 162 
Isocratic conditions of 5% solvent B were maintained for 15 min, followed by a gradient from 5 163 
to 10% B over 20 min and maintained for 5 min, then the % B was increased to 40% over 60 min 164 
and maintained 20 min. The flow rate was 1 ml/min. After passing the PDA flow cell, the eluate 165 
was split and 0.3 ml/min was directed to the mass spectrometer with the ESI operating in 166 
negative ionization mode. Analysis was initially carried out in full-scan, data-depending 167 
scanning from m/z 100 to 600 and identification was confirmed by single reaction monitoring 168 
and consecutive reaction monitoring. Calibration curves of standard were used to quantify 5-169 
CQA, hydroxycinnamic acids, dihydroferulic acid (DHF) and dihydrocaffeic acid (DHC). 170 
Coefficients of linearity for the calibration curves were typically R2>0.99. CGAs and 171 
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hydroxycinnamic acids were quantified by PDA at 325 nm, and 280 nm for DHC and DHF. 172 
Quantification of the other CGAs, namely feruloylquinic acids (FQA), dicaffeoylquinic acids 173 
(diCQA), p-coumaroylquinic acid (CoQA), caffeoyl-feruolylqunic aicd (CFQA), caffeoylqunic 174 
acid-lactone (CQAL) and feruloylqunic acid-lactone (FQAL) was performed using a 5-CQA 175 
calibration curve combined with molar extinction coefficients of the respective compound as 176 
reported by Trugo and Macrae (1984) and Farah et al. (2005).  177 
 178 
Statistics  179 
Results are shown as the mean ± standard deviation (SD). Student's t-test was applied for each 180 
CGA group to know whether there were differences among spent coffee and the coffee brew. 181 
One-way analysis of variance (ANOVA) was applied to determine significant differences (p ≤ 182 
0.05) between non-digested and digested samples. A T-Tukey test was applied as a test a 183 
posteriori with a level of significance of 95%. All statistical analyses were performed using 184 
STATA v.12.0. 185 
 186 
Results 187 
Characterization of spent coffee extracts 188 
Filter and espresso coffeemakers are commonly used to prepare a cup of coffee, not only in the 189 
home but also in workplaces and coffee shops. Arabica and Robusta coffees are the most 190 
consumed varieties. Previously it was shown that the spent coffees obtained after the preparation 191 
of a filter (Arabica coffee) and an espresso (Robusta coffee) coffee brew had the highest 192 
antioxidant activity in chemical-based assays and in cell cultures (Bravo et al. 2012; 2013). Thus, 193 
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the two spent coffees were each used to prepare an extract which were lyophilised, stored and 194 
reconstituted prior to analysis and testing, along with their respective coffee brews. A total of 33 195 
CGAs were identified and quantified in both spent coffee extracts and coffee brews with HPLC-196 
PDA-MSn, including two cinnamoyl-amino acid conjugates (Table 1). Identifications were 197 
performed by reference to published CGA fragmentation patterns (Clifford et al., 2003; Clifford 198 
& Knight, 2004). 199 
The results indicated that on a weight per weight basis, spent coffee contained higher 200 
amounts of CGAs than their respective coffee brew, especially after the production of espresso 201 
coffee (Table 2). On average, and a weight/weight basis, there was 6.2 ± 2.5% more CGAs 202 
quantified in the Arabica spent coffee compared with the brew, whereas 41 ± 2.4% more CGAs 203 
were recovered in Robusta spent coffee compared with the brew, mainly due to the higher CQAs 204 
from the spent coffee (44 ± 2.5%). Both spent coffee extracts showed similar amounts of total 205 
CGAs, but with profiles of different compounds, depending on the coffee bean variety. Arabica 206 
spent coffee contained higher amounts of CQAs, CoQAs and CQLs, while Robusta spent coffee 207 
was richer in FQAs, FQLs, C-FQAs and cinnamoyl-amino acids (Table 2).  208 
 209 
In vitro digestion 210 
The proximal gastrointestinal stability of the CGAs contained in Arabica and Robusta spent 211 
coffees was assessed using a three step in vitro model (Table 3 and Fig. 1). Table 3 summarizes 212 
the CGAs content of spent coffee extracts after simulated oral, gastric and intestinal digestion. 213 
The results indicated that the total CGA content of spent coffees decreased significantly by 4-214 
14% indicating degradation during the in vitro digestion process. However, successive in vitro 215 
digestions had little impact on CQAs and FQAs degradation, as shown by the stability in the 216 
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amounts recovered following incubations with digestive juice (Fig. 1). In contrast, the 217 
compounds most susceptible to oral, gastric and intestinal digestions were the lactones, CQL and 218 
FQL, with losses equivalent to 45-85% of the initial dose incubated (p < 0.001). CGA 219 
compounds responded differently to the enzymatic activity and pH changes. Robusta spent 220 
coffee showed more degradation of the CQA, FQA, CoQA and diCQA compounds, whereas 221 
lactones were more affected in Arabica compared to Robusta spent coffee.  222 
As mentioned above, overall CQAs and FQAs were relatively stable, although after in vitro 223 
digestion, there were changes due mainly to variations in isomer levels (Fig. 1). Firstly, the 224 
addition of α-amylase at pH 6.5-7 brought a decrease in the levels of 5-CQA, 17% (Arabica 225 
filter) and 20% (Robusta espresso) of the initial value (p <0.01), while the 3- and 4-CQA isomers 226 
increased significantly. The 3-acyl isomer showed an increase of 36-64% compared with the 227 
non-digested sample, while 4-CQA increased 11-25%. Similar results were observed for FQAs.  228 
Following the simulated oral digestion, the spent coffees and coffee brews were subjected 229 
to in vitro gastric digestion for 2 h. This reduced the concentrations of 3- and 4-CQA, although 230 
the final values remained, respectively, ca. 25 and 5% higher than non-digested sample. The last 231 
step was the addition of pancreatin and bile salt (pH 7), which had similar effects to those 232 
observed after oral digestion. The final concentration of the 5-acyl isomers were ca. 12% (CQA) 233 
and 19% (FQA) lower compared with the non-digested sample in both spent coffee samples. 234 
Moreover, the increment average of 3-acyl isomers was 50% of the initial value, and 16% for 4-235 
acyl isomers for Arabica filter spent coffee. In contrast, the increments of 3 and 4-acyl isomers 236 
were lower in Robusta espresso spent coffee, showing no significant differences with the non-237 
digested sample. 238 
 239 
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Absorption and metabolism of spent coffee CGAs and hydroxycinnamate standards 240 
The absorption study was performed with the digested Arabica spent coffee extract. The sample 241 
was incubated in Transwell cell culture inserts with a Caco-2 cell monolayer, which simulated 242 
the intestinal barrier. Table 4 shows the amount of CQAs found in the apical and basal 243 
compartments and in the Caco-2 cells as well as the percentage related to the initial amount 244 
loaded on the apical side. The results indicate that only 0.55% of the total CGAs were absorbed 245 
and transported from the apical to the basolateral side of cell in the first 0.5 h, and this increased 246 
to 1% after 1 h. Quinide lactones and CoQA were recovered in greater amounts on the 247 
basolateral side, accounting, respectively, for 33% and 17% of the amount incubated.  Other 248 
CGAs were subject to negligible transport from the apical to the basal cell.  DiCQAs showed an 249 
absorption of 0.6% and CQAs and FQAs of 0.3% and 0.5%, respectively. There was no 250 
difference in the transport of the different CQA and FQA isomers. In contrast to most of the 251 
CGAs, there was substantial transport of caffeine with 30% recovered on the basolateral side 252 
within 0.5 h and a further 6.5% taking place in the subsequent 0.5 h (Table 4). 253 
Further incubations were carried out to compare the absorption and metabolism of 254 
individual coffee components. Caco-2 cells were incubated with 5-CQA, 4,5-diCQA, caffeic 255 
acid, ferulic acid, dihydrocaffeic acid and dihydroferulic acid. Table 5 summaries the percentage 256 
of the initial dose remaining on the apical side after 0.5 h and 1 h, and that found in the Caco-2 257 
cells and the quantities transported to the basolateral side. Table 5 also provides information on 258 
metabolites produced. All the compounds were identified by comparing MSn fragmentation with 259 
patterns of previous works and reference compounds (Stalmach et al., 2009; Farrel et al., 2011b).  260 
Compounds with the highest basolateral recovery were ferulic acid and dihydroferulic acid, 261 
accounting for 5.9% and 5.3% of the apical dose, respectively, indicating a higher absorption and 262 
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basolateral transport than caffeic and dihydrocaffeic acids (<0.1% of the apical dose), 5-CQA 263 
(0.3%) and 4,5-DiCQA (0.5%). There was evidence of substantial metabolism principally in the 264 
form of isomerization of 5-CQA and 4,5-DiCQA. There was also low level i) hydrolysis of 265 
CQAs and DiCQA releasing caffeic acid, ii) sulphation of caffeic acid and ferulic acid, iii) 266 
methylation of caffeic acid yielding ferulic acid and iv) conversion of ferulic acid to 267 
dihydroferulic acid (Table 5). 268 
 269 
Discussion  270 
The by-product generated in the manufacture of coffee namely, spent coffee grounds, is a rich 271 
source of a diversity of CGAs. The aim of the present study was to assess the bioaccessibility of 272 
these compounds using Caco-2 cells and determine their stability in the proximal gastrointestinal 273 
tract, using a three step in vitro model of digestion to simulate the physiological conditions of the 274 
distal gastrointestinal tract.  275 
The stability of the various CGAs in the spent coffee extracts varied depending on the type 276 
of compounds, following incubation with simulated digestive juices corresponding to a model of 277 
oral, gastric and intestinal digestion. Our data are in line with previous reports that CGAs are 278 
stable when incubated with various gastrointestinal fluids (Olthof et al., 2001; Rechner et al., 279 
2001; Farah et al., 2006). Our results showed that the main CGAs in spent coffee, namely CQAs 280 
and FQAs were also subjected to isomerisation from the 5-acyl to 3- and 4- acyl loci, as 281 
previously reported in ileostomy volunteers (Erk et al., 2014). CGA isomer acyl migration was 282 
highly pH dependent. Basic pH condition (oral and intestinal digestion) showed an increase in 283 
the migration mainly to 3-acyl isomers, and this process was reversed in acid condition (gastric 284 
digestion), these are in agreement with Deshpande et al. (2014).  Moreover, our data showed that 285 
  14 
the seemingly high recoveries of CQA and FQA in the in vitro digestion model might be a 286 
consequence of the degradation of other components, such as diCQA and lactones in the spent 287 
coffee extracts. These two compounds showed a higher losses following incubation with 288 
gastrointestinal juices, which could have resulted to the release of the hydroxycinnamate moiety 289 
of diCQAs or the cleavage of the intramolecular ester bond of lactones. Previous research have 290 
reported positive health effect of lactones (de Paulis et al., 2002, 2004), however these activities 291 
might be limited, due to the high losses during the gastrointestinal digestion. Furthermore, the 292 
release of CQAs from other structures, including melanoidins, into which they are incorporated 293 
during roasting (Bekedam et al., 2008; Perrone et al., 2012), could also be hypothesised. In 294 
general, CGAs in spent coffee extracts were stable in the in vitro model of the proximal 295 
gastrointestinal tract implying that in vivo substantial amounts are likely to reach the colon.  This 296 
is in keeping with the reported 59-77% recoveries of CQAs in ileal fluid after the ingestion of 297 
coffee by ileostomists (Stalmach et al., 2010; Erk et al., 2012). 298 
CQA isomers in spent coffee were transported across the Caco-2 monolayer in only low 299 
amounts, corresponding to 0.3% of the apical dose. Similar absorption values have been reported 300 
for CQAs from coffee brew and standard solutions using similar Caco-2 cell models (Dupas et 301 
al., 2006; Farrell et al., 2012). Despite the different functions and morphology between gastric 302 
epithelial and Caco-2 cell monolayers, similar absorptive patterns were observed among both 303 
cellular lines. The absorption percentage of spent coffee CQAs was 0.3% of the apical dose, in 304 
agreement with the findings of Farrell et al. (2011a). In their study, Farrell et al. found that the 305 
percentage FQAs and CQLs transported across the gastric cell monolayer was slightly higher 306 
than that of CQAs. The only difference between gastric and intestinal cells was the percentage of 307 
diCQAs transported, due to the high permeability observed in gastric cells (Farrell et al., 2011a). 308 
  15 
The present study showed the first complete profile of phenolic compounds in spent coffee 309 
extracts, moreover cinnamoyl-amino acids had not been previously reported to occur in spent 310 
coffee grounds.  Furthermore, our study demonstrated higher levels of CGAs in spent coffee 311 
compared with the corresponding coffee brew, although with similar profiles of the individual 312 
CGAs. Robusta coffee spent extract contained ca. 40% more CGAs compared with the beverage 313 
(only 6% more CGAs in the Arabica spent coffee extract vs brew), which may have been due to 314 
the espresso brewing method used which is known for its low extraction efficiency (Cruz et al., 315 
2012).  316 
 317 
Conclusion 318 
Previous studies have highlighted a higher content of antioxidant and bioactive compounds 319 
in Arabica and Robusta spent coffee extracts compared with their respective coffee brews (Bravo 320 
et al., 2012, 2013). Our study demonstrated the high levels of unextracted CGAs in spent 321 
Arabica and Robusta spent coffee compared with the brews, and showed that the aqueous 322 
extracts of spent coffee were stable under gastrointestinal conditions and as bioaccessible as the 323 
compounds found in coffee beverage. Spent coffee extracts may therefore be suitable 324 
commercial source of CGAs as ingredients in functional foods or supplements.  325 
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Figure Legend 436 
Figure 1.  The impact of in vitro digestion model on the stability of the main CGAs isomers in 437 
spent coffee extracts. (A) Arabica spent coffee, (B) Robusta spent coffee. (      ) non-digested, 438 
(     ) oral digestion; (     ) gastric digestion, (     ) intestinal digestion. Data expressed as mean 439 
values ± standard deviation. Different letters in each isomer indicate significant differences (p 440 
< 0.05) between non-digested and digested samples (Analysis of variance with a pair-wise 441 
post-hoc comparison). 442 
 443 
 444 
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Table 1. Identification of chlorogenic acids in spent coffee and coffee brew*.  445 
 
Rt time 
(min) 
MS1  MS2  MS3 
Chlorogenic acids 
 Parent ion 
(m/z) 
 Base ion 
m/z 
Secondary ions 
m/z (intensity)              
 Base ion 
m/z 
Secondary ions 
m/z (intensity)              
O-Caffeoylquinic acid 9.6 353  191 179 (90), 135 (35)    
O-Caffeoylquinic acid 10.7 353  179 135(25), 191(20)     
3-O-Caffeoylquinic acid    12.6 353  191 179(65), 135(15)     
3-O-p-Coumaroylquinic acid 20.1 337  163 119(25)     
O-Caffeoylquinic acid 22.4 353  179 191(75), 135(25)     
O-Caffeoylquinic acid 23.8 353  191 179(10)     
4-O-Caffeoylquinic acid 25.0 353  173 179(95), 191(20), 135(15)     
5-O-Caffeoylquinic acid 32.4 353  191 179(5)     
3-O-Feruloylquinic acid 33.9 367  193 191(10)     
O-Caffeoylquinic acid lactone 38.4 335  179 161(60),135(35)     
4-O-p-Coumaroylquinic acid 41.6 337  173 163(10)     
3-O-Caffeoylquinic acid lactone 58.2 335  161 135(60),179(10)     
O-Caffeoylquinic acid lactone 62.5 335  173 179(25),161(25)     
5-O-p-Coumaroylquinic acid 63.2 337  191 179 (5)     
4-O-Caffeoylquinic acid lactone 64.6 335  161 135(15),179(15)     
4-O-Feruloylquinic acid 67.6 367  173 173(100), 193(30)     
O-Feruloylquinic acid 72.4 367  191 173(5)     
5-O-Feruloylquinic acid 79 367  191 179(10)     
O-Feruloylquinic acid lactone 84,4 349  193 175(30),134(15)     
O-Feruloylquinic acid lactone 91.7 349  175 149(50),193(30), 134(15)     
4-O-Feruloylquinic acid lactone 93.2 349  175 160(10)     
O-Feruloylquinic acid lactone 95.5 349  175 193(85),269(75),173(30),305(70),134(20)     
3,4-Di-O-caffeoylquinic acid 98,9 515  353 335(15), 179(15)  179 179(100),173(75),191(60) 
3,5-Di-O-caffeoylquinic acid 101.3 515  353 191(15)  191 191(100),179(65),135(15) 
4,5-Di-O-caffeoylquinic acid 109.8 515  353 173(10),179(10)  179 179(100),173(80),191(25),135(20) 
O-Caffeoyl-N-tryptophan 111.4 365  229 186(10),135(10)     
3-O-Caffeoyl-4-O-feruloylquinic acid 112.1 529  367 173(20),335(10)  173 193(40)  
3-O-Feruloyl-5-O-caffeoylquinic acid 113 529  367 335(15),173(10)  193 173 (45) 
3-O-Caffeoyl-5-O-feruloylquinic acid 114.2 529  353 367(40),191(10)  191 179(95) 
3-O-Feruloyl-4-O-caffeoylquinic acid 115.3 529  353 367(10),335(50)  179 191(20)  
p-Coumaroyl-N-tryptophan 120.6 349  229 186(15),145(5)     
4-O-Feruloyl-5-O-caffeoylquinic acid 121.4 529  367   173 193(50) 
4-O-Caffeoyl-5-O-feruloylquinic acid 123.8 529  353 367(30)  179 173(90),191(50) 
* HPLC-MSn retention time, [M-H]- , negatively charged molecular ion; MS2, daughter ions produced from [M-H]- fragmentation; MS3 , daughter 446 
ions produced from fragmentation of MS2 base ion. 447 
  448 
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 451 
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 453 
 454 
Table 2. Chlorogenic acids and caffeine content in Arabica and Robusta spent coffees extracts and coffee 455 
brews#.  456 
Compoundsa                      Arabica Robusta 
Spent coffee Coffee brew  Spent coffee Coffee brew 
Caffeoylquinic acids (7) 228 ± 6* 210 ± 2  186 ± 5* 129 ± 3 
Feruloylquinic acids (4)   34 ± 1*   28 ± 0    90 ± 3*   48 ± 1 
p-Coumaroylquinic acids (3)  9.9 ± 0.3*  9.3 ± 0.3   6.0 ± 0.2*  4.4 ± 0.1 
Dicaffeoylquinic acids (3)  3.6 ± 0.0*  2.7 ± 0.0   4.2 ± 0.4*  2.5 ± 0.1 
Caffeoylquinic acid lactones (4)   47 ± 3*   53 ± 1    37 ± 2*   43 ± 2 
Feruloylquinic acid lactones (4)  4.6 ± 0.6  5.0 ± 0.1   9.0 ± 0.5  9.8 ± 0.1 
Caffeoylferuloylquinic acids (6)  0.9 ± 0.0*  0.6 ± 0.0   3.8 ± 0.1*  1.9 ± 0.0 
Cinnamoyl-amino acids (2)  0.9 ± 0.0*  0.7 ± 0.0   9.4 ± 0.2*  7.2 ± 0.2 
Total chlorogenic acids (33) 329 ± 8* 309 ± 2  345 ± 4* 245 ± 4 
Caffeine 406 ± 40 395 ± 35         649 ± 39 671 ± 45 
#Data expressed in µmol/g of lyophilized spent coffee extract or coffee brew, as mean values ± standard 457 
deviation (n = 3). a Number of individual compounds corresponding to the sum for each group of 458 
chlorogenic acids. * Significant differences (p < 0.05) among spent coffee and its coffee brew (Student’s 459 
t-test). 460 
  461 
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Table 3. Chlorogenic acids content of Arabica and Robusta spent coffee extracts after the in vitro 462 
digestion model#.  463 
Compound Non-digested Oral digestion Gastric digestion Intestinal digestion 
Caffeoylquinic acids     
Arabica  228 ± 6a 256 ± 8 (112)b 234 ± 12 (103)a 244 ± 12 (107)ab 
Robusta 186 ± 5ab 194 ± 15 (104)b 169 ± 6 (91) a 179 ± 7 (96)ab 
Feruloylquinic acids     
Arabica  34 ± 1a 37 ± 1 (109)c 35 ± 1 (103)ab 36 ± 1 (106)bc 
Robusta 90 ± 3a 99 ± 6 (110)b 91 ± 4 (101)a 84 ± 6 (93)a 
p-Coumaroylquinic acids     
Arabica  9.9 ± 0.3b 9.0 ± 0.3 (91)a 9.6 ± 0.6 (97)ab 9.5 ± 0.3 (96)ab 
Robusta 6.0 ± 0.2a 6.4 ± 0.7 (107)a 5.1 ± 0.3 (85)b 4.5 ± 0.1 (75)b 
Dicaffeoylquinic acids     
Arabica  3.6 ± 0.0b 3.5 ± 0.1 (95)a 3.4 ± 0.1 (92)a 3.4 ± 0.0 (95)a 
Robusta 4.2 ± 0.4b 3.4 ± 0.5 (82)ab 3.3 ± 0.3 (80)a 3.5 ± 0.1 (84)ab 
Caffeoylquinide     
Arabica  47 ± 3c 7.7 ± 0.4 (16)a 17.5 ± 2.1 (37)b 8.2 ± 0.8 (17)a 
Robusta 37 ± 2c 15 ± 3 (41)a 20 ± 1 (54)b 17 ± 2 (46)a 
Feruloylquinide     
Arabica  4.6 ± 0.6b 1.0 ± 0.1 (22)a 1.3 ± 0.1 (28)a 0.9 ± 0.1 (20)a 
Robusta 9.0 ± 0.5b 4.6 ± 1.0 (51)a 5.0 ± 0.8 (56)a 5.3 ± 0.3 (59)a 
Caffeoylferuloylquinic acids     
Arabica  0.9 ± 0.0a 0.9 ± 0.0 (100)a 0.9 ± 0.0 (100)a 0.9 ± 0.0 (100)a 
Robusta 3.8 ± 0.1a 3.5 ± 0.4 (92)a 3.3 ± 0.3 (87)a 3.4 ± 0.1 (89)a 
Cinnamoyl-amino acids     
Arabica  0.9 ± 0.0a 1.0 ± 0.1 (111)b 0.9 ± 0.0 (100)ab 0.9 ± 0.0 (100)ab 
Robusta 9.4 ± 0.2a 8.7 ± 0.8 (93)a 8.5 ± 0.4 (90)a 9.0 ± 0.5 (96)a 
Total chlorogenic acids     
Arabica  329 ± 11b 316 ± 10 (96)ab 303 ± 10 (92)a 304 ± 15 (92)a 
Robusta 345 ± 11b 335 ± 28 (96)b 296 ± 13 (86)a 306 ± 15 (89)a 
#Data expressed in µmol/ g of lyophilized spent coffee extract non-digested or digested. Values are mean ± standard 464 
deviation from three independent experiments. Italicized numbers in brackets represent the recovery as a percentage 465 
of the non-digested sample.  Different superscripts within rows indicate significant differences (p < 0.05) between 466 
non-digested and digested samples (analysis of variance with a pair-wise post-hoc comparison).  467 
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 471 
Table 4. Transport of CGAs in spent coffee extracts across the Caco-2 cell monolayer after 0.5 and 1 h of incubation#. 472 
Compounds 
   
30 min  1h 
Apical Cell Basolateral  Apical Cell Basolateral 
Caffeoylquinic acids 1736 ± 31(99)  21 ± 2 (1.2)    3.6 ± 4 (0.2)  1659 ± 45 (98)  24.1 ± 3 (1.4) 5.4 ± 1.8 (0.3) 
Feruloylquinic acids   413 ± 10 (99) 3.6 ± 0.6 (0.9)    1.0 ± 0.0 (0.3)    404 ± 39 (98)     4.7± 1 (1.2) 2.1 ± 0.2 (0.5) 
p-Coumaroylquinic acids     34 ± 3 (90) 0.4 ± 0.1 (1.1)    3.3 ± 0.1 (8.8)      33 ± 5 (82)    0.5 ± 0.1 (1.2) 6.8 ± 0.9 (17) 
Dicaffeoylquinic acids     27 ± 1 (97) 0.8 ± 0.2 (3.0)    0.1 ± 0.0 (0.4)      23 ± 0 (96)    0.9 ± 0.2 (3.9) 0.1 ± 0.1 (0.6) 
Caffeoylquinide     16 ± 7 (76) 0.6 ± 0.3 (3.1)    4.4 ± 0.2 (21)      16 ± 6 (64)    0.7 ± 0.0 (3.0) 8.2 ± 0.7 (33) 
Total chlorogenic acids  2225 ± 75 (98)   27 ± 5 (1.2)     13 ± 1 (0.6)  2136 ± 95 (98) 31 ± 4 (1.4)  23 ± 4 (1.0) 
Caffeine 3517 ± 387 (67) 138 ± 42 (2.7) 1563 ± 42 (30)  2990 ± 591 (61)    139 ± 11 (2.8)   1798 ± 67 (37) 
#Data are expressed in nmol as means ± standard deviation from three independent experiments. Italicized numbers in brackets represent the amount of each 473 
individual CGA as the percentage of the initial apical dose.   474 
 475 
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Table 5. Transport and metabolism of CGAs and hydroxycinnamates across the Caco-2 Cell 476 
monolayer#.  477 
 478 
 479 
#Data expressed as a percentage of the apical dose of each standard solution, means from three independent 480 
experiments; tr = traces (< the limit of quantification); – not detected 481 
  482 
Compounds 
% of apical dose 
0.5 h  1 h 
Apical Cell Basolateral  Apical Cell Basolateral  
Substrate        
5-O-Caffeoylquinic acid 73.1  1.5  0.1   72.0  1.3  0.3  
Metabolites        
4-O-Caffeoylquinic acid 15.7  0.1  –  16.1  0.1  0.3 
3-O-Caffeoylquinic acid 9.1  – tr  9.4  – 0.1  
Caffeoylquinic acid-O-sulfate 0.1  tr tr  – tr – 
Caffeoylquinic acid-O-sulfate 0.2 tr tr  0.2  tr – 
Caffeic Acid – 0.1  0.0  0.0  – 0.1  
Total 98.2 1.7 0.1  97.7 1.5 0.8 
        
Substrate        
4,5-O-Dicaffeoylquinic acid 48.6  1.2  0.1   44.7  0.8 0.5  
Metabolites         
3,5-O-Dicaffeoylquinic acid 25.7  0.4  0.1   28.5  0.3  0.2  
3,4-O-Dicaffeoylquinic acid 10.0  0.1  –  13.3  0.1  0.1  
5-O-Caffeoylquinic acid 6.8  0.3 0.2   6.1  0.2  0.2  
4-O-Caffeoylquinic acid 3.3 tr tr  2.6  tr tr 
3-O-Caffeoylquinic acid 2.9   tr tr  2.1  tr tr 
Caffeic acid 0.3  0.1  –  0.2  0.1  0.1  
Total 97.6 2.0 0.4  97.5 1.4 1.0 
        
Substrate        
Caffeic acid 94.6 1.7 –  92.3 – – 
Metabolites        
Caffeic acid-3-O-sulfate 0.6 – –  1.4 – – 
Ferulic acid 3.0 – –  2.6 – 0.1 
Total  98.2 1.7 0.1  96.3 0.07 0.2 
        
Substrate        
Ferulic acid 95.5 0.9 3.5  92.3 0.6 5.9 
Metabolites        
Ferulic acid-4-O-sulfate – – –  – – 0.1 
Dihydroferulic acid tr tr tr  0.8 0.2 0.2 
Total  95.5 1.0 3.5  93.1 0.8 6.1 
        
Substrate        
Dihydrocaffeic acid 96.8 3.2 tr  96.8 3.1 0.0 
        
Substrate        
Dihydroferulic acid 96.2 1.7 2.1  93.2 1.5 5.3 
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